AKS Healthcare Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 8406218

AKS HEALTHCARE LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

28 February 2025

AKS HEALTHCARE LIMITED

OFFICERS AND PROFESSIONAL ADVISERS

The board of directors	Kartic Kohli
	Krishan Kohli

Registered office	38 Parklands
	Ponteland
	Newcastle upon Tyne
	NE20 9LL

Accountants	Hendersons
	Chartered Accountants
	Sterling House
	Brunswick Industrial Estate
	Wideopen
	Newcastle upon Tyne
	NE13 7BA

Bankers	Santander
	Customer Service Centre
	Bootle
	Mersyside
	L30 4GB

AKS HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION

28 February 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	6		3,293	5,536

Current assets

Stocks		55,450	54,460
Debtors	7	131,249	118,778
Cash at bank and in hand		798,395	704,730
		---------	---------
		985,094	877,968

Creditors: amounts falling due within one year	8	( 241,770)		( 228,964)
		---------		---------
Net current assets			743,324	649,004
			---------	---------
Total assets less current liabilities			746,617	654,540

Provisions

Taxation including deferred tax	( 823)	( 724)
	---------	---------
Net assets	745,794	653,816
	---------	---------

AKS HEALTHCARE LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

28 February 2025

	2025		2024
Note	£	£	£

Capital and reserves

Called up share capital	100	100
Profit and loss account	745,694	653,716
	---------	---------
Shareholders funds	745,794	653,816
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 15 September 2025 , and are signed on behalf of the board by:

Kartic Kohli

Director

Company registration number: 8406218

AKS HEALTHCARE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 28 FEBRUARY 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 38 Parklands, Ponteland, Newcastle upon Tyne, NE20 9LL.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Key sources of estimation uncertainty Goodwill amortisation - The directors are unable to arrive at a reliable estimate of the useful economic life of goodwill and consequently the presumed maximum life of 10 years as set out in FRS 102 has been adopted.

Revenue recognition

The turnover shown in the profit and loss account represents amounts taken in respect of prescriptions and other sales during the period, exclusive of Value Added Tax.

Corporation tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	10% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold property alterations	-	straight line over the lease term
Computer equipment	-	33% straight line
Other equipment	-	15% reducing balance

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks

Stocks are measured at the lower of cost and estimated selling price. Cost includes all costs of purchase and other costs incurred in bringing the stock to its present location and condition.

Provisions

Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 12 (2024: 11 ).

5. Intangible assets

	Goodwill
	£

Cost
At 1 March 2024 and 28 February 2025	599,451
	---------
Amortisation
At 1 March 2024 and 28 February 2025	599,451
	---------
Carrying amount
At 28 February 2025	–
	---------
At 29 February 2024	–
	---------

6. Tangible assets

Leasehold property alterations	Computer equipment	Other equipment	Total
£	£	£	£

Cost
At 1 March 2024	57,705	1,644	6,325	65,674
Additions	–	694	449	1,143
Disposals	–	( 304)	( 25)	( 329)
	--------	-------	-------	--------
At 28 February 2025	57,705	2,034	6,749	66,488
	--------	-------	-------	--------
Depreciation
At 1 March 2024	55,063	1,644	3,431	60,138
Charge for the year	2,642	231	500	3,373
Disposals	–	( 304)	( 12)	( 316)
	--------	-------	-------	--------
At 28 February 2025	57,705	1,571	3,919	63,195
	--------	-------	-------	--------
Carrying amount
At 28 February 2025	–	463	2,830	3,293
	--------	-------	-------	--------
At 29 February 2024	2,642	–	2,894	5,536
	--------	-------	-------	--------

7. Debtors

	2025	2024
	£	£

Trade debtors	91,842	94,898
Prepayments and accrued income	4,598	4,765
Other debtors	34,809	19,115
	---------	---------
	131,249	118,778
	---------	---------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£

Trade creditors	111,421	102,490
Accruals and deferred income	2,583	2,487
Corporation tax	50,566	47,345
Social security and other taxes	828	802
Director loan accounts	76,107	75,840
Other creditors	265	–
	---------	---------
	241,770	228,964
	---------	---------

9. Operating leases

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£

Not later than 1 year	–	12,250
Later than 5 years	240,625	–
	---------	--------
	240,625	12,250
	---------	--------

10. Directors' advances, credits and guarantees

Advances to the directors are accounted for as part of the movement on the directors' current accounts with the company. During the period total advances to Kartic Kohli amounted to £97 (2024 £457) and total credits to the account amounted to £209 (2024 £251). During the period total advances to Krishan Kohli amounted to £nil (2024 £nil) and total credits to the account amounted to £156 (2024 £156). Both accounts remained in credit throughout the period. No interest is applied to the directors' current accounts and there are no formal terms of repayment.

11. Related party transactions

Included in administrative expenses is a charge of £312 (2024 £312) in respect of business use of the directors' private residence. During the year the company paid dividends of £30,000 (2024 £30,000) to each of the directors.